Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Duloxetine may lessen peripheral neuropathy caused by chemotherapy. It is not yet
known whether duloxetine is more effective than a placebo in treating peripheral neuropathy
caused by chemotherapy.
PURPOSE: This randomized phase III trial is studying duloxetine to see how well it works
compared with a placebo in treating peripheral neuropathy caused by chemotherapy in patients
with cancer.